Sandoz launches direct-to-consumer platform with growth disorder drug

July 2, 2026 01:35 PM EDT Marketing San­doz tests di­rect-to-con­sumer sales with Om­ni­trope, a growth hor­mone biosim­i­lar Nicole DeFeudis Senior Reporter San­doz un­veiled a di­rect-to-con­sumer plat­form, start­ing off with a sin­gle med­ica­tion for now as the gener­ic drug­mak­er adopts a sys­tem that sev­er­al brand-name man­u­fac­tur­ers are … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER